Mid-Q Response Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.

Also called NCT04180696

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 177 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04180696
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Brunei, China, Hong Kong SAR China, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04180696. Randomized; single masking; primary purpose treatment. Start 2020-01-23 (actual); primary completion 2024-03-28 (actual). Results posted on 2025-05-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mid-Q Response Study
Condition
Heart Failure
Condition
Left Bundle-Branch Block
Condition
Heart Failure NYHA Class II
Condition
Heart Failure NYHA Class III
Condition
Heart Failure NYHA Class IV
Intervention (Device)
aCRT ON
Intervention (Device)
aCRT OFF
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)
Collaborator
Medtronic (class: industry)
Collaborator
Medtronic Japan Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04180696
Content hash
a67daa481496990fc4da3026fa2977d525391abc296e8b02901e8c7e504fd976